| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.088 | 0.05 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.086 | 0.06 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.075 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.062 | 0.2 |